1. Effect of folate-targeted Erlotinib loaded human serum albumin nanoparticles on tumor size and survival rate in a rat model of glioblastoma
   Morteza Kamali et al, 2023, Life Sciences CrossRef
2. Erlotinib-Induced Cardiomyopathy in a Patient with Metastatic Non-Small Cell Lung Cancer
   Kenji Nagashio et al, 2021, International Heart Journal CrossRef
3. Acute Coronary Syndrome Following Long-Term Erlotinib Treatment
   Traian Constantin Panciu et al, 2018, Internal Medicine CrossRef
4. Multimodality Advanced Cardiovascular and Molecular Imaging for Early Detection and Monitoring of Cancer Therapy-Associated Cardiotoxicity and the Role of Artificial Intelligence and Big Data
   Jennifer M. Kwan et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
5. Cardiovascular Complications by EGFR Tyrosine Kinase Inhibitors in Patients with Lung Cancer
   Koichi Kimura et al, 2021, International Heart Journal CrossRef
6. Assessment of Tyrosine Kinase Inhibitors and Survival and Cardiovascular Outcomes of Patients With Non–Small Cell Lung Cancer in Taiwan
   Wei-Ting Chang et al, 2023, JAMA Network Open CrossRef
7. Erlotinib
   , 2016, Reactions Weekly CrossRef
8. In SilicoPharmacoepidemiologic Evaluation of Drug-Induced Cardiovascular Complications Using Combined Classifiers
   Chuipu Cai et al, 2018, Journal of Chemical Information and Modeling CrossRef
9. Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer
   Yinan Yu et al, 2023, Current Treatment Options in Oncology CrossRef